Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Migraine

被引：0
|
作者：
Hennessy, Elise [1 ]
Salim, Amira [1 ]
Biswas, Sudipa [1 ]
Suneja, Aarushi [1 ]
Mays, Maryann [1 ]
Ahmed, Zubair [1 ]
Mata, Ignacio [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH USA
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000203028
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P10-12.005
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Anti-CGRP Monoclonal Antibodies for Neuropathic Pain in Patients with Migraine Headache
    Kang, Seung Ah
    Govindarajan, Raghav
    NEUROLOGY, 2021, 96 (15)
  • [42] Effectiveness of anti-CGRP monoclonal antibodies in the preventive treatment of migraine: A prospective study of 63 patients
    Castrillo, Ana
    Mendoza, Amelia
    Caballero, Lorena
    Cerdan, Debora
    Rodriguez, Maria Fernanda
    Guerrero, Pilar
    Tabernero, Cesar
    Ferrero, Marta
    Benito, Ines
    Marin, Laura
    Duarte, Jacinto
    MEDICINA CLINICA, 2023, 160 (08): : 341 - 346
  • [43] Future prophylactic treatments in migraine: Beyond anti-CGRP monoclonal antibodies and gepants
    Do, T. P.
    Al-Saoudi, A.
    Ashina, M.
    REVUE NEUROLOGIQUE, 2021, 177 (07) : 827 - 833
  • [44] Placebo effects in clinical trials of anti-CGRP monoclonal antibodies for migraine prevention
    Regnier, S.
    Lee, X. Ying
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [45] Could Symptom Severity Predict the Response to Anti-Cgrp Monoclonal Antibodies in Migraine?
    Membrilla, J. A.
    Ruiz Castrillo, M. J.
    Sastre Real, M.
    Sanchez Casado, L.
    Marino Trillo, E.
    Corral, C.
    Estebas, C.
    Gonzalez Sarmiento, R.
    Lorenzo, M.
    Diaz de Teran, J.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [46] Could symptom severity predict the response to anti-CGRP monoclonal antibodies in migraine?
    Membrilla, J.
    Ruiz Castrillo, M.
    Sastre Real, M.
    Sanchez Casado, L.
    Trillo Marino, E.
    Corral, C.
    Estebas, C.
    Gonzalez Sarmiento, R.
    Lorenzo, M.
    Diaz de Teran, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 413 - 413
  • [47] Treatment and management of migraine in neurological ambulatory practice in Poland by indicating therapy with monoclonal anti-CGRP antibodies
    Domitrz, Izabela
    Lipa, Aurelia
    Rozniecki, Jacek
    Stepien, Adam
    Kozubski, Wojciech
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2020, 54 (04) : 337 - 343
  • [48] Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
    Caronna, Edoardo
    Gallardo, Victor Jose
    Egeo, Gabriella
    Vazquez, Manuel Millan
    Castellanos, Candela Nieves
    Membrilla, Javier A.
    Vaghi, Gloria
    Rodriguez-Montolio, Joana
    Fabra, Neus Fabregat
    Sanchez-Caballero, Francisco
    Sanchez, Alex Jaimes
    Munoz-Vendrell, Albert
    Oliveira, Renato
    Garate, Gabriel
    Gonzalez-Osorio, Yesica
    Guisado-Alonso, Daniel
    Ornello, Raffaele
    Thunstedt, Cem
    Fernandez-Lazaro, Iris
    Torres-Ferrus, Marta
    Alpuente, Alicia
    Torelli, Paola
    Aurilia, Cinzia
    Pere, Raquel Lamas
    Castrillo, Maria Jose Ruiz
    De Icco, Roberto
    Sances, Grazia
    Broadhurst, Sarah
    Ong, Hui Ching
    Garcia, Andrea Gomez
    Campoy, Sergio
    Sanahuja, Jordi
    Cabral, Goncalo
    Blasco, Isabel Beltran
    Waliszewska-Prosol, Marta
    Pereira, Liliana
    Layos-Romero, Almudena
    Luzeiro, Isabel
    Dorado, Laura
    Escudero, Maria Rocio Alvarez
    May, Arne
    Lopez-Bravo, Alba
    Martins, Isabel Pavao
    Sundal, Christina
    Irimia, Pablo
    Ros, Alberto Lozano
    Gago-Veiga, Ana Beatriz
    Juanes, Fernando Velasco
    Ruscheweyh, Ruth
    Sacco, Simona
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (10): : 927 - 937
  • [49] Work impact and cost-effectiveness of anti-CGRP monoclonal antibodies in patients with migraine
    Lazaro, C.
    Caronna, E.
    Alpuente, A.
    De la Torre, A.
    Torres, M.
    Pozo-Roisch, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 487 - 488
  • [50] Dual Therapy With Anti-CGRP Monoclonal Antibodies and Botulinum Toxin for Migraine Prevention: Is There a Rationale?
    Pellesi, Lanfranco
    Do, Thien P.
    Ashina, Hakan
    Ashina, Messoud
    Burstein, Rami
    HEADACHE, 2020, 60 (06): : 1056 - 1065
12345